A Bayesian approach for mixed effects state‐space models under skewness and heavy tails

Human immunodeficiency virus (HIV) dynamics have been the focus of epidemiological and biostatistical research during the past decades to understand the progression of acquired immunodeficiency syndrome (AIDS) in the population. Although there are several approaches for modeling HIV dynamics, one of...

Full description

Saved in:
Bibliographic Details
Published inBiometrical journal Vol. 65; no. 8; pp. e2100302 - n/a
Main Authors Hernandez‐Velasco, Lina L., Abanto‐Valle, Carlos A., Dey, Dipak K., Castro, Luis M.
Format Journal Article
LanguageEnglish
Published Germany Wiley - VCH Verlag GmbH & Co. KGaA 01.12.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Human immunodeficiency virus (HIV) dynamics have been the focus of epidemiological and biostatistical research during the past decades to understand the progression of acquired immunodeficiency syndrome (AIDS) in the population. Although there are several approaches for modeling HIV dynamics, one of the most popular is based on Gaussian mixed‐effects models because of its simplicity from the implementation and interpretation viewpoints. However, in some situations, Gaussian mixed‐effects models cannot (a) capture serial correlation existing in longitudinal data, (b) deal with missing observations properly, and (c) accommodate skewness and heavy tails frequently presented in patients' profiles. For those cases, mixed‐effects state‐space models (MESSM) become a powerful tool for modeling correlated observations, including HIV dynamics, because of their flexibility in modeling the unobserved states and the observations in a simple way. Consequently, our proposal considers an MESSM where the observations' error distribution is a skew‐t. This new approach is more flexible and can accommodate data sets exhibiting skewness and heavy tails. Under the Bayesian paradigm, an efficient Markov chain Monte Carlo algorithm is implemented. To evaluate the properties of the proposed models, we carried out some exciting simulation studies, including missing data in the generated data sets. Finally, we illustrate our approach with an application in the AIDS Clinical Trial Group Study 315 (ACTG‐315) clinical trial data set.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0323-3847
1521-4036
DOI:10.1002/bimj.202100302